HOME >> BIOLOGY >> NEWS
Drug decreases blood vessel stiffness in older primates

A novel drug that breaks down vascular collagen bonds in the body significantly decreased the stiffness of blood vessels in older non-human primates, according to a study conducted by National Institute on Aging (NIA) scientists and others.* The finding suggests the medication could be a new treatment for high blood pressure, heart failure, and certain vascular complications of diabetes.

ALT-711 (Alteon, Ramsey, New Jersey), a thiazolium-based compound, snips bonds or crosslinks created in the arteries and other tissues when glucose attaches to collagen. Crosslinks are cable-like structures that inhibit the natural flexibility of collagen strands. They tend to proliferate with age. Crosslinks appear to toughen tissues and may cause some of the deterioration associated with aging and diabetes, such as elevated systolic blood pressure, hardened arteries, and impaired kidney function.

In the study, six rhesus monkeys received doses of ALT-711 every other day for three weeks. Six weeks after the last treatment, all of the vessel walls tested were more flexible, and the effect persisted for more than four months after final administration of the drug. Blood flow through the heart also increased and this improvement persisted for nearly 10 months after the treatments ended. No significant changes in body weight or routine chemical measurements were detected during the follow-up period. The finding was published in the January 30, 2001 issue of Proceedings of the National Academy of Sciences.

Arterial stiffening is a major factor in many of the vascular diseases associated with advancing age, said Edward Lakatta, M.D., co-author of the study and chief of the NIAs

Laboratory of Cardiovascular Sciences. The significance of this drug is it alters the properties of the arterial wall and makes it easier for the heart to eject blood into the blood vessels. These results, coupled with prior studies in smaller animals, certainly suggest that
'"/>

Contact: Doug Dollemore
dollemod@nia.nih.gov
301-496-1752
NIH/National Institute on Aging
29-Jan-2001


Page: 1 2

Related biology news :

1. Breastfeeding decreases infant mortality
2. Complement inhibitor decreases heart attacks and death in men following cardiac surgery
3. Sepsis drug fights infection, decreases hospital care over two year study
4. Rock climbing decreases biodiversity
5. New study of healthy men finds semen quality decreases with age
6. Smoking decreases mens chances of fatherhood by IVF and ICSI
7. Estrogen receptor-{alpha} antisense decreases brain estrogen receptor levels and affects ventilation in male and female rats
8. Experimental drug decreases age-related blood vessel stiffening
9. Meditation decreases blood pressure
10. Experimental drug shown to block mutant protein causing blood disease
11. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... BARBARA, Calif. (PRWEB) , ... July 21, 2020 ... ... firm driving digital transformation and innovation in technology and compliance, announces a new ... medical device companies must ensure every layer of their technology stack complies with ...
(Date:7/4/2020)... ... 03, 2020 , ... Aesthetics Biomedical (ABM), a leading aesthetics ... not only the products and treatments developed, but also the dedicated team behind ... the brands built by ABM have received several honors already for 2020, each ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... software solutions for biopharmaceutical R&D, today announced that it has entered into ... full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... LORTON, Va. (PRWEB) , ... July 08, 2020 ... ... laboratory testing services and products, announces a significant expansion of laboratory operations through ... robust collection for agencies implementing testing programs. , Bode-CARES provides ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... ... called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in zebrafish embryos, ... PolyU research team led by Dr MA has been using the zebrafish model ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
(Date:7/1/2020)... ... 2020 , ... MedShift , a leading medical technology ... obstacles created as a result of COVID-19. As a provider at the forefront ... and medical manufacturers by expanding access to device offerings, technology services, and marketing ...
Breaking Biology Technology:
Cached News: